High-Dose Radiation increases Notch1 in tumor vasculature.
The aim of this study is to characterize the effects of high-dose radiation therapy (HDRT) on Notch signaling components of the tumor vasculature. Human umbilical vein endothelial cells (HUVEC) monolayers were exposed to different single fraction doses of irradiation, RNA was isolated and PCR was performed for Notch signaling components. The vascular response to radiation therapy was examined in a xenograft model of neuroblastoma. Tumors were treated with 0 Gy, 2 Gy and 12 Gy single fraction doses, and analyzed by double immunofluorescence staining for Notch1, Notch ligands Jagged1 and Dll4 and the endothelial cell (EC) marker endomucin. To assess the role of Notch in vivo, NGP xenograft tumors expressing Fc or Notch1-1-24-decoy (a novel Notch inhibitor) were treated with 0 Gy and 12 Gy. Immunofluorescence staining for endomucin and endomucin/αSMA was performed to analyze the effect of combination treatment on tumor EC and endothelial-to-mesenchymal-transition (EndMT), respectively. In HUVEC monolayers doses ≥ 8 Gy increased expression of NOTCH1, JAG1 and Notch target genes HEY1 and HEY2 as early as 6 hr after irradiation. In vivo, 12 Gy significantly increased Notch1 and Jagged1 in tumor ECs, when compared with 0 Gy or 2 Gy, after 72 hr. Combining HDRT with Notch inhibition using the Notch1-1-24-decoy, resulted in a greater loss of EC coverage of tumor vessels than HDRT alone at 6 hr and 72 hr post treatment. Notch inhibition reduced EndMT induced by HDRT, as indicated by diminished αSMA staining in ECs. HDRT induced Notch1 expression and increased Notch1 signaling in the endothelial component of tumor vasculature, which was not observed with lower doses. This increase in Notch1 activation might protect tumor vessels from HDRT induced damage and regulate EndMT process.